Factors associated with reduced antituberculous serum drug concentrations in patients with HIV-TB coinfection. (Q45131685)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875581%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

title

Factors associated with reduced antituberculous serum drug concentrations in patients with HIV-TB coinfection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875581%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875581%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

Rabia Ahmed

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875581%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Ryan Cooper

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875581%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Michelle Foisy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875581%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Evelina Der

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875581%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

publication date

8 August 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875581%20AND%20SRC:MED&resulttype=core&format=json

Journal of the International Association of Providers of AIDS Care

10 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875581%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875581%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875581%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

273-276

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875581%20AND%20SRC:MED&resulttype=core&format=json

Malabsorption of rifampin and isoniazid in HIV-infected patients with and without tuberculosis

10 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1545109712454454

Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clini

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109712454454

Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109712454454

Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109712454454

Therapeutic drug monitoring in the treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109712454454

Reduced antituberculosis drug concentrations in HIV-infected patients who are men or have low weight: implications for international dosing guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109712454454

Therapeutic drug monitoring of antimycobacterial drugs in patients with both tuberculosis and advanced human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109712454454

Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109712454454

Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109712454454

Pharmacokinetic evaluation of rifabutin in combination with lopinavir-ritonavir in patients with HIV infection and active tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109712454454

Pharmacokinetics and tolerability of a higher rifampin dose versus the standard dose in pulmonary tuberculosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109712454454

21 January 2018

Identifiers

DOI

10.1177/1545109712454454

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22875581%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference